Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (41-50 of 288) with videos related to

Pageof 29
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologiesDavid E Gerber, Paul K Paik, Afshin Dowlati
Clinical Pharmacology : Advances and Applications|April 15, 2015
Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathwaysGaurab Chakrabarti, David E Gerber, David A Boothman
Lung Cancer (Amsterdam, Netherlands)|March 19, 2013
Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancerBercin Kutluk Cenik, Han Sun, David E Gerber
Immunotherapy|August 17, 2011
Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatmentPaul DeRose, Philip E Thorpe, David E Gerber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple MyelomaEthan A Halm, Larry D Anderson, David E Gerber
JAMA Oncology|October 2, 2015
Next-Generation Sequencing for the Identification of Targetable Molecular Alterations in CancerMartin F Dietrich, Robert H Collins, David E Gerber
Journal of Comparative Effectiveness Research|August 15, 2015
Should criteria for inclusion in cancer clinical trials be expanded?David E Gerber, Sandi L Pruitt, Ethan A Halm
JAMA Oncology|November 30, 2023
Contemporary Trends in Reviewing Test Results Through the Electronic Patient Portal Among Patients With CancerSheena Bhalla, Tanushree Prasad, Donglu Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Management of venous thromboembolism in patients with primary and metastatic brain tumorsDavid E Gerber, Stuart A Grossman, Michael B Streiff
Clinical Chemistry|May 5, 2020
Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and DiagnosisMitchell S von Itzstein, Shaheen Khan, David E Gerber
Pageof 29

Showing results (41-50 of 288) with videos related to

Sort By:
Pageof 29
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologiesDavid E Gerber, Paul K Paik, Afshin Dowlati
Clinical Pharmacology : Advances and Applications|April 15, 2015
Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathwaysGaurab Chakrabarti, David E Gerber, David A Boothman
Lung Cancer (Amsterdam, Netherlands)|March 19, 2013
Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancerBercin Kutluk Cenik, Han Sun, David E Gerber
Immunotherapy|August 17, 2011
Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatmentPaul DeRose, Philip E Thorpe, David E Gerber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Understanding the Relationship Between Care Volume and Clinical Outcomes in Multiple MyelomaEthan A Halm, Larry D Anderson, David E Gerber
JAMA Oncology|October 2, 2015
Next-Generation Sequencing for the Identification of Targetable Molecular Alterations in CancerMartin F Dietrich, Robert H Collins, David E Gerber
Journal of Comparative Effectiveness Research|August 15, 2015
Should criteria for inclusion in cancer clinical trials be expanded?David E Gerber, Sandi L Pruitt, Ethan A Halm
JAMA Oncology|November 30, 2023
Contemporary Trends in Reviewing Test Results Through the Electronic Patient Portal Among Patients With CancerSheena Bhalla, Tanushree Prasad, Donglu Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Management of venous thromboembolism in patients with primary and metastatic brain tumorsDavid E Gerber, Stuart A Grossman, Michael B Streiff
Clinical Chemistry|May 5, 2020
Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and DiagnosisMitchell S von Itzstein, Shaheen Khan, David E Gerber
Pageof 29